Do Not Treat Group C Streptococcal Pharyngitis in Asymptomatic or Minimally Symptomatic Adults
In a healthy 45-year-old with only a scratchy throat and a positive Group C streptococcal culture, antibiotics should be withheld because Group C streptococcus is not an established cause of acute rheumatic fever or other serious sequelae that justify routine treatment, and current guidelines focus exclusively on Group A streptococcus as the sole bacterial pathogen requiring specific therapy in pharyngitis. 1, 2
Why Group C Streptococcus Does Not Warrant Treatment
Guidelines target only Group A streptococcus: The IDSA explicitly states that Group A streptococcus (GAS) is the only common bacterial pathogen in acute pharyngitis that requires antimicrobial therapy to prevent acute rheumatic fever and suppurative complications. 1, 2
No rheumatic fever risk with Group C: Unlike Group A streptococcus, Group C and G streptococci have not been definitively linked to acute rheumatic fever, which is the primary justification for treating streptococcal pharyngitis. 1
Minimal symptoms argue against treatment: A "scratchy throat" without fever, severe pain, tonsillar exudate, or systemic symptoms does not meet the clinical threshold for bacterial pharyngitis requiring antibiotics. 1, 2
Possible colonization vs. infection: Group C streptococcus may represent asymptomatic colonization rather than active infection, particularly when symptoms are minimal. 1
Clinical Context for Group C Streptococcus
Group C and G streptococci (Streptococcus dysgalactiae subspecies equisimilis) can occasionally cause pharyngitis with clinical features similar to Group A streptococcal infection, including fever, exudate, and cervical adenopathy. 3, 4
These organisms have been associated with reactive arthritis and, rarely, post-streptococcal glomerulonephritis (primarily with zoonotic strains), but not with acute rheumatic fever. 3, 5
Most reported cases of symptomatic Group C pharyngitis involve patients with significant fever, exudate, and adenopathy—not isolated mild throat discomfort. 4
When to Consider Treatment of Group C Streptococcus
Severe symptomatic pharyngitis: If the patient had high fever (≥38.9°C), marked tonsillar exudate, severe throat pain, and tender cervical lymphadenopathy—mimicking classic streptococcal pharyngitis—some clinicians might consider a 10-day course of penicillin or amoxicillin, though this is not guideline-supported. 4
Immunocompromised or high-risk patients: In patients with underlying conditions predisposing to invasive streptococcal disease, treatment might be considered on a case-by-case basis. 3
Recurrent or persistent symptoms: If symptoms worsen or persist beyond 3–4 days, reassess for suppurative complications or alternative diagnoses. 2
Recommended Management for This Patient
Symptomatic treatment only: Offer ibuprofen or acetaminophen for throat discomfort. 2
Reassurance: Explain that most sore throats are viral and self-limited, resolving within 3–7 days without antibiotics. 2
No routine follow-up testing: Do not retest asymptomatic patients or household contacts. 1, 2
Reevaluate if symptoms worsen: If fever, severe pain, dysphagia, or systemic symptoms develop, consider suppurative complications (peritonsillar abscess, cervical lymphadenitis) or alternative diagnoses. 2
Common Pitfalls to Avoid
Do not treat based on culture results alone when symptoms are minimal or absent; this leads to unnecessary antibiotic exposure and promotes resistance. 1, 2
Do not assume all β-hemolytic streptococci require treatment; only Group A streptococcus has established links to acute rheumatic fever and other serious sequelae. 1, 2
Do not test or treat asymptomatic household contacts of patients with Group C streptococcal pharyngitis. 1, 2